Bernardo Gradin Will Head Braskem
Chemical and Engineering News (Free subscription) | 07/07/2008
Predecessor Jose Grubisich will join parent company Odebrecht's bioenergy business
- add comment
- send to a friend
- Explore : Braskem, Chemicals
Chemical and Engineering News (Free subscription) | 07/07/2008
Predecessor Jose Grubisich will join parent company Odebrecht's bioenergy business
Chemical and Engineering News (Free subscription) | 07/07/2008
Department of Homeland Security sends letters to high-risk facilities
Chemical and Engineering News (Free subscription) | 07/07/2008
Number two nylon maker may sell its business to focus on specialties
Chemical and Engineering News (Free subscription) | 07/07/2008
Chemical coating winnows tiny carbon tubes by chirality
Chemical and Engineering News (Free subscription) | 07/07/2008
Canadian facility will be first to produce ethanol from solid waste on an industrial scale
Chemical and Engineering News (Free subscription) | 03/07/2008
Selenium sorbent lowers risk of mercury exposure from light bulbs
Chemical and Engineering News (Free subscription) | 02/07/2008
Blending solids leads to stable ionic liquid and efficient energy conversion device
Chemical and Engineering News (Free subscription) | 02/07/2008
Electrostatic repulsion detects DNA pairing
Chemical and Engineering News (Free subscription) | 01/07/2008
Canadian scientist will receive $460,000 for pioneering work on cell signaling
Chemical and Engineering News (Free subscription) | 01/07/2008
Chemical manufacturers seek tariff elimination in multilateral Doha deal
Chemical and Engineering News (Free subscription) | 01/07/2008
Doughnut-shaped polymeric particles could be used as cellular tags and for drug delivery
Nature (Free subscription) | 01/07/2008
Establishing networks that tackle issues ranging from drug development bottlenecks to manufacturing standards has become a key part of Europe's strategy to improve its global competitiveness. Bethan Hughes investigates progress so far.
Nature (Free subscription) | 01/07/2008
Which studies made a splash at this year's American Society of Clinical Oncology meeting?
Nature (Free subscription) | 01/07/2008
Current available therapies for eye diseases associated with abnormal retinal vascular permeability, such as age-related macular degeneration, require repeated intraocular injection. Now, Scheppke and colleagues, writing in The Journal of Clinical Investigation, describe a tyrosine kinase inhibitor that can be topically applied to reduce
Nature (Free subscription) | 01/07/2008
The ongoing debate on the creation of an abbreviated regulatory pathway for 'follow-on' versions of innovator biologics in the United States highlights questions about the current balance between incentives for innovation and price competition in general.